---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-043491"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2025-10-01T23:59:59+00:00"
generated_at: "2026-05-17T05:04:15.234069+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sanuwave Health appoints Coyle COO, removes Stegagno; terminates President Walko

## Summary
- Daniel Coyle appointed COO effective Sept 25, 2025; previously VP of Engineering.
- Former COO Peter Stegagno removed, appointed Chief Regulatory Officer; no longer an executive officer.
- President Andrew Walko terminated without cause effective Oct 24, 2025; no new President planned.
- Coyle's base salary set at $225,000, bonus at 40% of salary, and options for 60,000 shares vesting quarterly.

## SEC filing metadata
- accession: 0001628280-25-043491
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2025-10-01T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828025043491/0001628280-25-043491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828025043491/snwv-20250925.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-043491
- JSON: https://secwatch.observer/filing/0001628280-25-043491.json
- Plain text: https://secwatch.observer/filing/0001628280-25-043491.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.